Glaxosmithkline | GSK - Interest Income

Stock Price
59.20
Daily Change
10.91 22.59%
Monthly
21.54%
Yearly
62.73%
Q1 Forecast
50.58

Glaxosmithkline reported GBP26M in Interest Income for its fiscal quarter ending in September of 2025.





Interest Income Change Date
AbbVie USD 72M 10M Sep/2025
AstraZeneca USD 68M 16M Jun/2025
Aurora Cannabis CAD 1.85M 120K Sep/2025
Bausch Health Companies USD 13M 2M Jun/2025
Corcept Therapeutics USD 5.02M 1.18M Jun/2025
Drreddys Laboratories INR 796M 332M Dec/2025
Eli Lilly USD 65M 25M Sep/2025
GlaxoSmithKline GBP 26M 24M Sep/2025
Glaxosmithkline GBP 26M 24M Sep/2025
J&J USD 2.12 0.17 Sep/2025
Merck USD 96M 27M Sep/2025
Pacira USD 5.01M 1.89M Jun/2025
Pfizer USD 0.62 156M Sep/2025
Sanofi EUR 114M 38M Sep/2025
Supernus Pharmaceuticals USD 4.53M 103K Jun/2025
Takeda JPY 87.87B 43.48B Dec/2025
Zoetis USD 19M 4M Jun/2025